Unity Biotechnology, Inc.

UBX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$26-$40-$60-$61
Dep. & Amort.$1$1$2$3
Deferred Tax$0$0$0$1
Stock-Based Comp.$4$7$9$12
Change in WC$3-$4-$1-$1
Other Non-Cash-$3-$1-$2$1
Operating Cash Flow-$21-$39-$51-$45
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0-$40
Inv. Purchases$0-$29-$99-$81
Inv. Sales/Matur.$0$89$74$121
Other Inv. Act.$9$0$0$40
Investing Cash Flow$9$60-$25$39
Financing Activities
Debt Repay.$0-$20$0-$0
Stock Issued$0$5$58$19
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$1$0$2
Financing Cash Flow$0-$16$56$21
Forex Effect$0$0$0$0
Net Chg. in Cash-$12$7-$21$15
Supplemental Information
Beg. Cash$21$14$34$19
End Cash$8$21$14$34
Free Cash Flow-$21-$37-$51-$45